To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Vermillion Announces Issuance of Patent for Lung Cancer
Read time: Less than a minute
"This patent highlights on-going progress in expanding our intellectual property portfolio. Beyond our core focus areas of ovarian cancer and peripheral artery disease, we now have patents in lung cancer, breast cancer, and Alzheimer's disease. It is our goal to explore business opportunities to leverage this growing and valuable asset of the Company," said Gail S. Page, CEO of Vermillion.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
